182 related articles for article (PubMed ID: 29910171)
1. Characterization of breast lesion using T
Thakran S; Gupta PK; Kabra V; Saha I; Jain P; Gupta RK; Singh A
Diagn Interv Imaging; 2018 Oct; 99(10):633-642. PubMed ID: 29910171
[TBL] [Abstract][Full Text] [Related]
2. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
[TBL] [Abstract][Full Text] [Related]
3. Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.
Kim SG; Freed M; Leite APK; Zhang J; Seuss C; Moy L
J Magn Reson Imaging; 2017 May; 45(5):1385-1393. PubMed ID: 27766710
[TBL] [Abstract][Full Text] [Related]
4. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
[TBL] [Abstract][Full Text] [Related]
5. Assessment of quantitative dynamic contrast-enhanced MRI in distinguishing different histologic grades of breast phyllode tumor.
Yi Z; Xie M; Shi G; Cheng Z; Zeng H; Jiang N; Wu Z
Eur Radiol; 2022 Mar; 32(3):1601-1610. PubMed ID: 34491383
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of quantitative pharmacokinetic parameters and relative quantitative pharmacokinetic parameters in breast lesions with dynamic contrast-enhanced MRI].
Sun TT; Liu WH; Zhang YQ; Li LH; Wang R; Ye YY
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(29):2266-2270. PubMed ID: 28780840
[No Abstract] [Full Text] [Related]
7. Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
Cheng Z; Wu Z; Shi G; Yi Z; Xie M; Zeng W; Song C; Zheng C; Shen J
Eur Radiol; 2018 Mar; 28(3):982-991. PubMed ID: 28929243
[TBL] [Abstract][Full Text] [Related]
8. Preoperative predicting malignancy in breast mass-like lesions: value of adding histogram analysis of apparent diffusion coefficient maps to dynamic contrast-enhanced magnetic resonance imaging for improving confidence level.
Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
Br J Radiol; 2017 Nov; 90(1079):20170394. PubMed ID: 28876982
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
[TBL] [Abstract][Full Text] [Related]
10. Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration?
Wake N; Chandarana H; Rusinek H; Fujimoto K; Moy L; Sodickson DK; Kim SG
Magn Reson Imaging; 2018 Oct; 52():16-23. PubMed ID: 29777820
[TBL] [Abstract][Full Text] [Related]
11. Improving suspicious breast lesion characterization using semi-automatic lesion fractional volume washout kinetic analysis.
Huang J; Hahn T; Hoisington L; Schafer S; Zong X; Berger K
Med Phys; 2011 Nov; 38(11):5998-6009. PubMed ID: 22047364
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of acute benign and malignant vertebral body fractures using dynamic contrast-enhanced MRI.
Geith T; Biffar A; Schmidt G; Sourbron S; Dürr HR; Reiser M; Baur-Melnyk A
AJR Am J Roentgenol; 2013 Jun; 200(6):W635-43. PubMed ID: 23701095
[TBL] [Abstract][Full Text] [Related]
13. Performance evaluation of texture analysis based on kinetic parametric maps from breast DCE-MRI in classifying benign from malignant lesions.
Jiang Z; Yin J
J Surg Oncol; 2020 Jun; 121(8):1181-1190. PubMed ID: 32167588
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Abbreviated MRI and Full Diagnostic MRI in Distinguishing between Benign and Malignant Lesions Detected by Breast MRI: A Multireader Study.
Kim ES; Cho N; Kim SY; Kwon BR; Yi A; Ha SM; Lee SH; Chang JM; Moon WK
Korean J Radiol; 2021 Mar; 22(3):297-307. PubMed ID: 33289355
[TBL] [Abstract][Full Text] [Related]
15. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
Chen W; Giger ML; Bick U; Newstead GM
Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
[TBL] [Abstract][Full Text] [Related]
17. Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps.
Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
Clin Radiol; 2018 May; 73(5):460-466. PubMed ID: 29295753
[TBL] [Abstract][Full Text] [Related]
18. Whole-lesion apparent diffusion coefficient (ADC) metrics as a marker of breast tumour characterization-comparison between ADC value and ADC entropy.
Bougias H; Ghiatas A; Priovolos D; Veliou K; Christou A
Br J Radiol; 2016 Dec; 89(1068):20160304. PubMed ID: 27718592
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of diffusion kurtosis imaging in characterization of breast lesions.
Christou A; Ghiatas A; Priovolos D; Veliou K; Bougias H
Br J Radiol; 2017 May; 90(1073):20160873. PubMed ID: 28383279
[TBL] [Abstract][Full Text] [Related]
20. Kinetic Curve Type Assessment for Classification of Breast Lesions Using Dynamic Contrast-Enhanced MR Imaging.
Yang SN; Li FJ; Chen JM; Zhang G; Liao YH; Huang TC
PLoS One; 2016; 11(4):e0152827. PubMed ID: 27055113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
